Blog
RSS FeedPosted by Michael Wonder on 21 Jul 2021
Biogen Alzheimer's drug slow to take off as U.S. Medicare wrestles with coverage
21 July 2021 - U.S. hospitals that were expected to be early adopters of Biogen’s Alzheimer’s drug have treated only a ...
Posted by Michael Wonder on 21 Jun 2021
Factors associated with generic drug uptake in the United States, 2012 to 2017
19 June 2021 - In the United States, brand-name prescription drugs remain expensive until market exclusivity ends and lower cost generics ...
Posted by Michael Wonder on 15 Jun 2021
Uptake of medicines for type 2 diabetes mellitus
15 June 2021 - Empagliflozin (with and without metformin hydrochloride) has been funded since 1 February 2021. It is funded for ...
Posted by Michael Wonder on 03 Jun 2021
EU regulators develop recommendations to forecast demand of medicines
3 June 2021 - The EU Executive Steering Group on Shortages of Medicines Caused by Major Events has adopted a ...
Posted by Michael Wonder on 18 May 2021
Sandoz Canada congratulates the Quebec government on implementing a shift towards biosimilars
18 May 2021 - The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta ...
Posted by Michael Wonder on 18 May 2021
Almost one-third of adult Australians say they’re unlikely to get COVID vaccination: survey
19 May 2021 - Almost one-third of adult Australians say they are unlikely to be vaccinated against COVID-19 in a ...
Posted by Michael Wonder on 17 May 2021
One in four COVID vaccine doses distributed in Australia not yet administered, figures show
17 May 2021 - New figures show one in four COVID-19 vaccines available in Australia have not been administered, with GP ...
Posted by Michael Wonder on 11 May 2021
CMS expanding efforts to grow COVID-19 vaccine confidence and uptake amongst nation’s most vulnerable
11 May 2021 - CMS builds on whole of Government COVID-19 response with vaccination education, offering and reporting. ...
Posted by Michael Wonder on 06 May 2021
Alberta, Canada, begins mandating switches from originator to biosimilar Humira
6 May 2021 - Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar ...
Posted by Michael Wonder on 29 Apr 2021
Australia has surpassed 2 million vaccines but lacks data on second doses
28 April 2021 - Australians will not be told how many people have received a second dose of the COVID-19 vaccine ...
Posted by Michael Wonder on 10 Apr 2021
Doctors stop offering AstraZeneca jabs over legal risk
11 April 2021 - Many of the nation’s GPs are refusing to offer AstraZeneca’s vaccine to people under 50 until ...
Posted by Michael Wonder on 23 Mar 2021
Increasingly, Europeans do not trust AstraZeneca’s vaccine
22 March 2021 - Hesitancy could put the continent’s exit strategy from the pandemic at risk. ...
Posted by Michael Wonder on 18 Mar 2021
Drug Utilisation SubCommittee utilisation analysis public release documents
18 March 2021 - The utilisation analysis public release documents from the October 2020 Drug Utilisation SubCommittee meeting are now available. ...
Posted by Michael Wonder on 16 Mar 2021
Once again, the viability of the U.S. biosimilar market is thrown into question
15 March 2021 - Despite periodic reports that biosimilars have finally arrived and will save the U.S. health care system ...
Posted by Michael Wonder on 09 Mar 2021
Pfizer COVID vaccine: states agree to secrecy over unused jabs
10 March 2021 - Australian states and territories have made a secret agreement not to release weekly data to the public ...